Adjuvant treatment with interleukin-2- and interferon-alpha2a-based chemoimmunotherapy in renal cell carcinoma post tumour nephrectomy: Results of a prospectively randomised Trial of the German Cooperative Renal Carcinoma Chemoimmunotherapy Group (DGCIN)
Article
Atzpodien, J, Schmitt, E, Gertenbach, U, Fornara, P, Heynemann, H, Maskow, A, Ecke, M, Wöltjen, H H, Jentsch, H, Wieland, W, Wandert, T and Reitz, M (2005) Adjuvant treatment with interleukin-2- and interferon-alpha2a-based chemoimmunotherapy in renal cell carcinoma post tumour nephrectomy: Results of a prospectively randomised Trial of the German Cooperative Renal Carcinoma Chemoimmunotherapy Group (DGCIN). British Journal of Cancer 92 (5), pp. 843-846.Alternative links to fulltext
Involved Institutions
Details
| Item type | Article | ||||
| Journal or Publication Title | British Journal of Cancer | ||||
| Publisher | NATURE PUBLISHING GROUP | ||||
| Place of Publication | LONDON | ||||
| Volume | 92 | ||||
| Number of Issue or Book Chapter | 5 | ||||
| Page Range | pp. 843-846 | ||||
| Date | 2005 | ||||
| Date of publication | 19 Dec 2024 15:03 | ||||
| Institutions | Medicine > Lehrstuhl für Urologie | ||||
| Identification Number |
| ||||
| Keywords | DOSE BOLUS INTERLEUKIN-2; INTERFERON-ALPHA; RADICAL NEPHRECTOMY; PHASE-III; 5-FLUOROURACIL; CANCER; COMBINATION; VACCINE; RISK; adjuvant; immunotherapy; renal cell carcinoma | ||||
| Dewey Decimal Classification | 600 Technology > 610 Medical sciences Medicine | ||||
| Status | Published | ||||
| Refereed | Yes, this version has been refereed | ||||
| Created at the University of Regensburg | Yes | ||||
| Item ID | 70853 |
Export bibliographical data
Owner only: item control page
Altmetric
Altmetric